Common name
ethylene glycol
IUPAC name
ethylene glycol
SMILES
C(O)CO
Common name
ethylene glycol
IUPAC name
ethylene glycol
SMILES
C(O)CO
INCHI
InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2
FORMULA
C2H6O2
Common name
ethylene glycol
IUPAC name
ethylene glycol
Molecular weight
62.068
clogP
-0.637
clogS
0.629
Frequency
0.0265
HBond Acceptor
2
HBond Donor
2
Total PolarSurface Area
40.46
Number of Rings
0
Rotatable Bond
1
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00477 | Bisoprolol |
|
Antihypertensive Agents; Adrenergic beta-1 Receptor Antagonists; Sympatholytics; Cardiovascular System; Agents Acting on the Renin-Angiotensin System; Beta Blocking Agents, Selective; Beta Blocking Agents; Beta Blocking Agents, Selective, and Thiazides; Beta Blocking Agents and Thiazides; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For management of heart failure, angina pectoris, and mild to moderate hypertension and for secondary prevention of myocardial infarction (MI). |
| FDBD00516 | Dyphylline |
|
Phosphodiesterase Inhibitors; Bronchodilator Agents; Vasodilator Agents; Muscle Relaxants, Respiratory; Respiratory System; Drugs for Obstructive Airway Diseases; Xanthines; Xanthines and Adrenergics; | For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. |
| FDBD00606 | Mannitol |
|
Sweetening Agents; Diuretics, Osmotic; Blood and Blood Forming Organs; Mucolytics; Cough and Cold Preparations; Respiratory System; Alimentary Tract and Metabolism; Blood Substitutes and Perfusion Solutions; Irrigating Solutions; Osmotically Acting Laxatives; Drugs for Constipation; Solutions Producing Osmotic Diuresis; i.v. Solutions; | Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances. |
| FDBD00649 | Aciclovir |
|
Antiviral Agents; Nucleic Acids, Nucleotides, and Nucleosides; Ophthalmologicals; Sensory Organs; Antiinfectives for Systemic Use; Dermatologicals; Direct Acting Antivirals; Antivirals for Systemic Use; Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors; Antiinfectives; | For the treatment and management of herpes zoster (shingles), genital herpes, and chickenpox. |
| FDBD00716 | Chlorphenesin |
|
Muscle Relaxants, Central; Dermatologicals; Antifungals for Topical Use; Antifungals for Dermatological Use; CYP3A4 Inhibitors; | Used along with rest and physical therapy to treat injuries and other painful muscular conditions. Investigated for use in trigeminal neuralgia (tic douloureux); a neuropathic disorder characterized by severe facial pain. Was investigated as a modulator of histamine release. |
| FDBD00726 | Alprenolol |
|
Antihypertensive Agents; Sympatholytics; Anti-Arrhythmia Agents; Adrenergic beta-Antagonists; Cardiovascular System; Beta Blocking Agents; Beta Blocking Agents, Non-Selective; CYP2D6 Inducers; CYP2D6 Inducers (strong); | For the treatment of hypertension, angina, and arrhythmia. |
| FDBD00734 | Guaifenesin |
|
Expectorants; Cough and Cold Preparations; Respiratory System; Musculo-Skeletal System; Muscle Relaxants, Centrally Acting Agents; Muscle Relaxants; | Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections. |
| FDBD00815 | Pindolol |
|
Antihypertensive Agents; Vasodilator Agents; Serotonin Antagonists; Adrenergic beta-Antagonists; Cardiovascular System; Beta Blocking Agents; Beta Blocking Agents, Non-Selective; CYP2D6 Inducers; CYP2D6 Inducers (strong); | For the management of hypertension, edema, ventricular tachycardias, and atrial fibrillation. |
| FDBD00857 | Cromoglicic acid |
|
Anti-Asthmatic Agents; Respiratory System; Ophthalmologicals; Sensory Organs; Drugs for Obstructive Airway Diseases; Alimentary Tract and Metabolism; Dermatologicals; Nasal Preparations; Adrenergics, Inhalants; Intestinal Antiinflammatory Agents; Antidiarrheals, Intestinal Anti-Inflammatory/antiinfective Agents; Agents for Dermatitis, Excluding Corticosteroids; Decongestants and Antiallergics; Antiallergic Agents, Excl. Corticosteroids; | For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. |
| FDBD00858 | Ganciclovir |
|
Antiviral Agents; Ophthalmologicals; Sensory Organs; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors; Antiinfectives; | For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients. |
77 ,
8
